<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000347382"><TermName>Kinaret</TermName><TermPronunciation>(KIH-nuh-ret)</TermPronunciation><TermDefinition><DefinitionText>A substance that is used to treat rheumatoid arthritis, and is being studied in the treatment of cancer. Kinaret blocks the action of interleukin 1 (IL-1). It is a type of interleukin receptor antagonist. Also called anakinra.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000731653" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Kinaret&quot;" language="en" id="_3"/><MediaLink ref="CDR0000731652" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Kinaret&quot;" language="es" id="_4"/><SpanishTermName>Kinaret</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia que se usa para tratar la artritis reumatoide y que está en estudio para el tratamiento de cáncer. Kinaret bloquea la acción de la interleucina 1 (IL-1). Es un tipo de antagonista del receptor de interleucina. También se llama anakinra.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-12-23</DateFirstPublished><DateLastModified>2007-01-18</DateLastModified></GlossaryTerm>
